LexDanaLexDanabeta
New SessionSearchOfficial RankingsInsightsPricing
© LexDana · beta
LexDanaLexDanabeta
New SessionSearchOfficial RankingsInsightsPricing
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets14Federal Circuit179Pharma & ANDA40PTAB150Supreme Court9USPTO Policy27Patent Litigation55Patent Prosecution20ITC / Section 33732Trademark43Unsorted35

Tagged orange book · clear

Pharma & ANDA

Reading an Orange Book Listing the Way a Litigator Would

An Orange Book entry is an assertion, not an adjudication — and the difference is where most ANDA disputes actually live. Three things to check first 1. Use codes. They frame the carve out fight before anyone files. 2. Expiry versus exclusivity. They are…

July 29, 2026·Pharma & ANDA·1 min read
LexDana
AskSearchRankingsInsightsPricingProfileContactTermsPrivacy
The LexDana Docket
Monthly — what shipped, who moved, what we published.
© 2026 LexDana, Inc.·Powered by Patexia data